Gene expression microarray analysis reveals prognostic markers of survival in high grade astrocytomas

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Neurological Research

• Publication date

  2018-05-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/01616412.2018.1475126PMID 29781781
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients

  2016cited by this paper
• miR-3646 promotes cell proliferation, migration, and invasion via regulating G2/M transition in human breast cancer cells.

  2016cited by this paper
• Modeling Survival Data Extending The Cox Model

  2016cited by this paper
• The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge

  2015cited by this paper
• MAP4K4 deletion inhibits proliferation and activation of CD4(+) T cell and promotes T regulatory cell generation in vitro.

  2014cited by this paper
• Targeting CDC25C, PLK1 and CHEK1 to overcome Docetaxel resistance induced by loss of LZTS1 in prostate cancer

  2014cited by this paper
• CHK1 levels correlate with sensitization to pemetrexed by CHK1 inhibitors in non-small cell lung cancer cells.

  2013cited by this paper
• Combination therapy targeting the Chk1 and Wee1 kinases shows therapeutic efficacy in neuroblastoma.

  2013cited by this paper
• STRING v9.1: protein-protein interaction networks, with increased coverage and integration

  2012cited by this paper
• Increased Immune Gene Expression and Immune Cell Infiltration in High-Grade Astrocytoma Distinguish Long-Term from Short-Term Survivors

  2012influential reference
• CHK1 targets spleen tyrosine kinase (L) for proteolysis in hepatocellular carcinoma.

  2012cited by this paper
• TargetMine, an Integrated Data Warehouse for Candidate Gene Prioritisation and Target Discovery

  2011cited by this paper
• Malignant pleural mesothelioma: genome-wide expression patterns reflecting general resistance mechanisms and a proposal of novel targets.

  2010cited by this paper
• New Insights into Checkpoint Kinase 1 in the DNA Damage Response Signaling Network

  2010cited by this paper
• pleural mesothelioma : Genome-wide expression patterns reflecting eneral resistance mechanisms and a proposal of novel targets luf

  2009cited by this paper
• Different molecular patterns in glioblastoma multiforme subtypes upon recurrence

  2009cited by this paper
• Prognostic Value of Perfusion MR Imaging of High-Grade Astrocytomas: Long-Term Follow-Up Study

  2008cited by this paper
• The 2007 WHO Classification of Tumours of the Central Nervous System

  2007cited by this paper
• Survivin subcellular localization in high-grade astrocytomas: simultaneous expression in both nucleus and cytoplasm is negative prognostic marker

  2007cited by this paper
• Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.

  2006cited by this paper
• Genetic pathways to glioblastomas

  2005cited by this paper
• DrugBank: a comprehensive resource for in silico drug discovery and exploration

  2005cited by this paper
• Biostatistics: a Methodology for the Health Sciences

  2005cited by this paper
• Inhibition of Human Chk1 Causes Increased Initiation of DNA Replication, Phosphorylation of ATR Targets, and DNA Breakage

  2005cited by this paper
• New opportunities in chemosensitization and radiosensitization: modulating the DNA-damage response

  2005cited by this paper
• Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

  2005cited by this paper
• Cytoscape: a software environment for integrated models of biomolecular interaction networks.

  2003cited by this paper
• Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma.

  2002cited by this paper
• Missing value estimation methods for DNA microarrays

  2001cited by this paper
• Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy.

  1999cited by this paper
• Connections between growth and the cell cycle.

  1998cited by this paper
• The phosphatidylinositol 3′ kinase pathway is required for the survival signal of leukocyte tyrosine kinase

  1997cited by this paper
• Examples of Survival Data

  1997cited by this paper
• Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3.

  1994cited by this paper
• Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

  1993cited by this paper
• An Introduction to Kernel and Nearest-Neighbor Nonparametric Regression

  1992cited by this paper
• Cox Analysis of Survival Data with Non‐Proportional Hazard Functions

  1992cited by this paper
• Leukocytes express a novel gene encoding a putative transmembrane protein-kinase devoid of an extracellular domain

  1988cited by this paper
• The classification of tumours of the central nervous system.

  1982cited by this paper

• Microarray gene expression profiling and bioinformatics analysis reveal key differentially expressed genes in clival and sacral chordoma cell lines

  2019cites this paper
• Over ten years overall survival in glioblastoma: A different disease?

  2019cites this paper